COVID-19 reached pandemic proportions due to the emergence of SARS-CoV-2 variants such as B.1.1.7, B.1.1.529, BA.2 with increased transmissibility and the ability to evade immune response against the spike (S) glycoprotein, which helps in the virus entry to the host cell. This evidence concerns the gene CHMP5 and COVID-19.